Literature DB >> 16918463

The strength of weak interactions: aromatic fluorine in drug design.

Stephen G Dimagno1, Haoran Sun.   

Abstract

Selective aromatic fluorine substitution can increase the affinity of a molecule for a macromolecular recognition site through non-covalent interactions. These effects are evaluated most accurately by direct comparison of binding affinities of selectively fluorinated compounds with their corresponding hydrocarbons. In cases where structural data confirm similar binding geometries for the fluorocarbon and hydrocarbon analogues, reliable estimates for the impact of fluorination upon arene-pi...X and C-F...X interaction energies are possible. Existing studies show that fluorination's impact on any individual molecular interaction is quite modest. Upon binding to a protein receptor, cumulative fluorinated aromatic quadrupolar and C-F...X dipolar interaction energies rarely differ from those the corresponding hydrocarbons by more than 1.3 kcal/mol, and most individual interactions appear to be in the 0.1-0.4 kcal/mol range. Similarly, non-ideal selective fluorination is rarely associated with a dramatic decrease in affinity, because the impact of weak repulsive interactions in the bound state is counterbalanced by increased lipophilicity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16918463     DOI: 10.2174/156802606777951127

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  14 in total

1.  Fluorine-18 Radiolabeled PET Tracers for Imaging Monoamine Transporters: Dopamine, Serotonin, and Norepinephrine.

Authors:  Jeffrey S Stehouwer; Mark M Goodman
Journal:  PET Clin       Date:  2009-01

2.  Mannitol Bis-phosphate Based Inhibitors of Fructose 1,6-Bisphosphate Aldolases.

Authors:  Charles-Gabin Mabiala-Bassiloua; Guillaume Arthus-Cartier; Véronique Hannaert; Hélène Thérisod; Jurgen Sygusch; Michel Thérisod
Journal:  ACS Med Chem Lett       Date:  2011-09-03       Impact factor: 4.345

3.  A structural and functional perspective into the mechanism of Ca2+-sensitizers that target the cardiac troponin complex.

Authors:  Ian M Robertson; Yin-Biao Sun; Monica X Li; Brian D Sykes
Journal:  J Mol Cell Cardiol       Date:  2010-08-27       Impact factor: 5.000

4.  Discovery of a Potent HIV Integrase Inhibitor that Leads to a Prodrug with Significant anti-HIV Activity.

Authors:  Byung I Seo; Vinod R Uchil; Maurice Okello; Sanjay Mishra; Xiao-Hui Ma; Malik Nishonov; Qingning Shu; Guochen Chi; Vasu Nair
Journal:  ACS Med Chem Lett       Date:  2011-10-05       Impact factor: 4.345

5.  Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing.

Authors:  Rohan Patil; Suranjana Das; Ashley Stanley; Lumbani Yadav; Akulapalli Sudhakar; Ashok K Varma
Journal:  PLoS One       Date:  2010-08-16       Impact factor: 3.240

Review 6.  A medicinal chemist's guide to molecular interactions.

Authors:  Caterina Bissantz; Bernd Kuhn; Martin Stahl
Journal:  J Med Chem       Date:  2010-07-22       Impact factor: 7.446

7.  P1 and P1' para-fluoro phenyl groups show enhanced binding and favorable predicted pharmacological properties: structure-based virtual screening of extended lopinavir analogs against multi-drug resistant HIV-1 protease.

Authors:  Ravikiran S Yedidi; Zhigang Liu; Iulia A Kovari; Patrick M Woster; Ladislau C Kovari
Journal:  J Mol Graph Model       Date:  2013-11-01       Impact factor: 2.518

8.  Full and Partial Agonism of a Designed Enzyme Switch.

Authors:  S Jimmy Budiardjo; Timothy J Licknack; Michael B Cory; Dora Kapros; Anuradha Roy; Scott Lovell; Justin Douglas; John Karanicolas
Journal:  ACS Synth Biol       Date:  2016-07-22       Impact factor: 5.110

9.  Synthesis and Characterization of a Diazirine-Based Photolabel of the Nonanesthetic Fropofol.

Authors:  E Railey White; David M Leace; Victoria M Bedell; Natarajan V Bhanu; Benjamin A Garcia; William P Dailey; Roderic G Eckenhoff
Journal:  ACS Chem Neurosci       Date:  2020-12-23       Impact factor: 4.418

10.  Anticancer, antioxidant activities, and DNA affinity of novel monocationic bithiophenes and analogues.

Authors:  Mohamed A Ismail; Reem K Arafa; Magdy M Youssef; Wael M El-Sayed
Journal:  Drug Des Devel Ther       Date:  2014-09-29       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.